MCM2 (P49736) variants and mutations
MCM2 (also known as P49736) is a human protein-coding gene encoding a DNA replication licensing factor protein. It is part of the MCM2-7 helicase that unwinds DNA at replication forks and licenses origins before S phase. Excess or dysregulated expression is common in proliferative cancers and is widely used as a marker of active DNA replication. This analysis covers 1,263 MCM2 variants and mutations. Of these, 79% have computational variant effect predictions. Disease context includes autosomal dominant nonsyndromic hearing loss 70, autosomal dominant nonsyndromic hearing loss, and Abnormality of the gastrointestinal tract. Example MCM2 variants include M1I, A2E, and A2S.
Variant analysis overview
- Gene: MCM2
- Protein: P49736
- UniProt accession: P49736
- Organism: Homo sapiens
- Variants analyzed: 1263
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 992 unspecified-consequence records; 132 missense variants; 4 splice-region variants; 1 splice acceptor variant; 104 synonymous variants; 11 in-frame deletions; 12 frameshift variants; 6 stop-gained variants; 1 substitution
- Prediction scores: 994 variants have prediction scores (79% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: autosomal dominant nonsyndromic hearing loss 70, autosomal dominant nonsyndromic hearing loss, Abnormality of the gastrointestinal tract, deafness, myopathy, alcohol drinking, urolithiasis, risk-taking behaviour, hepatocellular carcinoma, breast cancer, cancer, cervical carcinoma.
Protein structure and variant hotspots
- Protein features: 1 domains; 2 binding sites; 18 post-translational modification sites.
- Structural context: 363 variants have structural context.
- PTM context: 39 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable MCM2 variants
Examples include M1I, A2E, A2S, A2T, A2V, A2P, A2A, E3K. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs1439380101, ClinGen CA354379151, ClinVar RCV003856052, MetaLR 0.01, MetaSVM -0.94, Uncertain significance, not provided
- A2E (p.Ala2Glu), rs1247401070, ClinGen CA354379177, ClinVar RCV002021143, ClinVar RCV006287592, REVEL 0.17, MetaLR 0.02, Uncertain significance, not provided; not specified
- A2S (p.Ala2Ser), TOPMed rs1180671901, REVEL 0.11, MetaLR 0.02
- A2T (p.Ala2Thr), TOPMed rs1180671901, REVEL 0.17, MetaLR 0.02
- A2V (p.Ala2Val), TOPMed rs1247401070, gnomAD rs1247401070, REVEL 0.16, MetaLR 0.02, Uncertain significance
- A2P (p.Ala2Pro), gnomAD 3-127598470-G-C, REVEL 0.18, MetaLR 0.02
- A2A (p.Ala2Ala), rs777313854, gnomAD 3-127598472-G-A, CADD 28.80
- E3K (p.Glu3Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E3E (p.Glu3Glu), gnomAD 3-127599320-A-G, CADD 15.20
- S5P (p.Ser5Pro), ExAC rs779411453, gnomAD rs779411453, REVEL 0.20, MetaLR 0.01
- p.Ser5 Ser7del, rs1326816597, gnomAD 3-127599316-AGGAA, CADD 25.50
- S5W (p.Ser5Trp), gnomAD 3-127599325-C-G, REVEL 0.21, MetaLR 0.02
- S5L (p.Ser5Leu), gnomAD 3-127599325-C-T, REVEL 0.17, MetaLR 0.01
- S5S (p.Ser5Ser), rs148166817, gnomAD 3-127599326-G-A, CADD 1.93
- E6Q (p.Glu6Gln), gnomAD 3-127599327-G-C, REVEL 0.19, MetaLR 0.01
- S7Y (p.Ser7Tyr), TOPMed rs2074287101, REVEL 0.13, MetaLR 0.01
- S7S (p.Ser7Ser), rs1207593703, gnomAD 3-127599332-C-T, CADD 10.50
- F8del (p.Phe8del), rs2074287174, gnomAD 3-127599331-CCTT-, CADD 17.70
- T9I (p.Thr9Ile), NCI-TCGA Cosmic COSV5403, Variant assessed as somatic; moderate impact.
- T9A (p.Thr9Ala), gnomAD 3-127599336-A-G, REVEL 0.07, MetaLR 0.00
- M10T (p.Met10Thr), ExAC rs772081346, gnomAD rs772081346
- M10V (p.Met10Val), gnomAD rs1323537239
- A11T (p.Ala11Thr), ExAC rs773331466, TOPMed rs773331466, gnomAD rs773331466, REVEL 0.07, MetaLR 0.07, Uncertain significance, not specified
- A11A (p.Ala11Ala), gnomAD 3-127599344-A-G, CADD 3.83
- S12C (p.Ser12Cys), gnomAD rs1410210990, REVEL 0.05, MetaLR 0.09
- S12Y (p.Ser12Tyr), gnomAD 3-127599346-C-A, REVEL 0.07, MetaLR 0.09
- S12F (p.Ser12Phe), gnomAD 3-127599346-C-T, REVEL 0.07, MetaLR 0.09
- S12S (p.Ser12Ser), gnomAD 3-127599347-C-G, CADD 8.95
- S13N (p.Ser13Asn), TOPMed rs2074287537
- S13R (p.Ser13Arg), rs1201891506, ClinGen CA354380156, ClinVar RCV002639932, Uncertain significance, not provided
- S13I (p.Ser13Ile), gnomAD 3-127599349-G-T, REVEL 0.18, MetaLR 0.17
- S13S (p.Ser13Ser), rs1201891506, gnomAD 3-127599350-C-T, CADD 9.80
- P14A (p.Pro14Ala), ExAC rs778688260, TOPMed rs778688260, gnomAD rs778688260, REVEL 0.15, MetaLR 0.18, Uncertain significance, not provided; not specified
- P14L (p.Pro14Leu), ExAC rs771192544, gnomAD rs771192544, REVEL 0.25, MetaLR 0.18
- P14R (p.Pro14Arg), ExAC rs771192544, gnomAD rs771192544, REVEL 0.26, MetaLR 0.18
- P14S (p.Pro14Ser), ExAC rs778688260, TOPMed rs778688260, gnomAD rs778688260, REVEL 0.18, MetaLR 0.18
- P14P (p.Pro14Pro), rs376102107, gnomAD 3-127599353-G-C, CADD 0.80
- A15V (p.Ala15Val), TOPMed rs2074287843, REVEL 0.05, MetaLR 0.09
- p.Ala15 Pro28del, rs2074287456, gnomAD 3-127599344-ATCCA, CADD 20.60
- A15A (p.Ala15Ala), rs911567815, gnomAD 3-127599356-C-T, CADD 7.97
- Q16H (p.Gln16His), rs1444746944, ClinGen CA354380191, ClinVar RCV002029893, TOPMed rs1444746944, AlphaMissense 0.10, MetaLR 0.05, Uncertain significance, not provided
- Q16P (p.Gln16Pro), gnomAD 3-127599358-A-C, REVEL 0.06, MetaLR 0.05
- R17C (p.Arg17Cys), ExAC rs765085888, gnomAD rs765085888, REVEL 0.15, MetaLR 0.11
- R17H (p.Arg17His), Ensembl rs866230256, REVEL 0.13, MetaLR 0.09
- R17G (p.Arg17Gly), gnomAD 3-127599360-C-G, REVEL 0.09, MetaLR 0.07
- R18P (p.Arg18Pro), rs185298481, ClinGen CA2595462, ClinVar RCV003236536, ClinVar RCV003549026, REVEL 0.12, MetaLR 0.06, Benign/Likely benign, Autosomal dominant nonsyndromic hearing loss 70; not specified; not provided
- R18Q (p.Arg18Gln), 1000Genomes rs185298481, ExAC rs185298481, TOPMed rs185298481, gnomAD rs185298481, REVEL 0.05, MetaLR 0.06, Benign
- R18W (p.Arg18Trp), rs775610133, ClinGen CA2595461, ClinVar RCV003850582, ExAC rs775610133, REVEL 0.09, MetaLR 0.08, Uncertain significance, not provided
- R18L (p.Arg18Leu), gnomAD 3-127599364-G-T, REVEL 0.10, MetaLR 0.08
- R18R (p.Arg18Arg), rs751073432, gnomAD 3-127599365-G-T, CADD 8.56
- R19* (p.Arg19Ter), TOPMed rs1348376063, gnomAD rs1348376063, CADD 33.00
- R19P (p.Arg19Pro), ExAC rs756651624, gnomAD rs756651624
- R19Q (p.Arg19Gln), ExAC rs756651624, gnomAD rs756651624, REVEL 0.07, MetaLR 0.07
- R19E (p.Arg19Glu), rs1334001164, gnomAD 3-127599363-CG-C, CADD 23.30
- R19G (p.Arg19Gly), gnomAD 3-127599366-C-G, REVEL 0.06, MetaLR 0.08
- G20D (p.Gly20Asp), gnomAD 3-127599370-G-A, REVEL 0.06, MetaLR 0.04
- N21D (p.Asn21Asp), gnomAD rs1307579099, REVEL 0.07, MetaLR 0.06
- N21S (p.Asn21Ser), gnomAD 3-127599373-A-G, REVEL 0.04, MetaLR 0.04
- D22G (p.Asp22Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D22N (p.Asp22Asn), gnomAD rs1321006847, REVEL 0.06, MetaLR 0.06
- P23L (p.Pro23Leu), rs2074288488, ClinGen CA354380356, ClinVar RCV003720578, TOPMed rs2074288488, REVEL 0.07, MetaLR 0.06, Uncertain significance, not provided
- P23S (p.Pro23Ser), gnomAD 3-127599378-C-T, REVEL 0.03, MetaLR 0.05
- P23R (p.Pro23Arg), gnomAD 3-127599379-C-G, REVEL 0.06, MetaLR 0.06
- L24F (p.Leu24Phe), ExAC rs767165577
- L24V (p.Leu24Val), gnomAD 3-127599381-C-G, REVEL 0.06, MetaLR 0.07
- L24L (p.Leu24Leu), rs1242541059, gnomAD 3-127599383-C-T, CADD 11.60
- T25I (p.Thr25Ile), ExAC rs750028509, gnomAD rs750028509, REVEL 0.06, MetaLR 0.10
- T25P (p.Thr25Pro), Ensembl rs1576410052
- S26F (p.Ser26Phe), gnomAD 3-127599388-C-T, REVEL 0.19, MetaLR 0.11
- S27G (p.Ser27Gly), gnomAD rs1359617924, REVEL 0.17, MetaLR 0.12
- S27I (p.Ser27Ile), gnomAD rs1203986622, REVEL 0.24, MetaLR 0.16
- S27T (p.Ser27Thr), gnomAD 3-127599391-G-C, REVEL 0.15, MetaLR 0.14
- P28A (p.Pro28Ala), TOPMed rs1249227952, gnomAD rs1249227952
- P28L (p.Pro28Leu), TOPMed rs2074288865
- P28S (p.Pro28Ser), TOPMed rs1249227952, gnomAD rs1249227952, REVEL 0.26, MetaLR 0.21
- P28H (p.Pro28His), gnomAD 3-127599394-C-A, REVEL 0.24, MetaLR 0.22
- P28P (p.Pro28Pro), gnomAD 3-127599395-T-G, CADD 7.15
- G29S (p.Gly29Ser), Ensembl rs2074288909, REVEL 0.04, MetaLR 0.05
- G29G (p.Gly29Gly), gnomAD 3-127599398-C-T, CADD 13.30
- R30* (p.Arg30Ter), rs1181496683, NCI-TCGA Cosmic COSV9941, TOPMed rs1181496683, gnomAD rs1181496683, CADD 36.00, Variant assessed as somatic; high impact.
- R30G (p.Arg30Gly), TOPMed rs1181496683, gnomAD rs1181496683, REVEL 0.06, MetaLR 0.06
- R30P (p.Arg30Pro), gnomAD rs1183303134
- R30Q (p.Arg30Gln), gnomAD rs1183303134, REVEL 0.02, MetaLR 0.06
- R30R (p.Arg30Arg), gnomAD 3-127599401-A-G, CADD 6.33
- S31I (p.Ser31Ile), ExAC rs755366699, TOPMed rs755366699, gnomAD rs755366699, REVEL 0.07, MetaLR 0.07
- p.Ser31 Arg44del, rs754592078, gnomAD 3-127599380-TCTCA, CADD 21.70
- S31S (p.Ser31Ser), rs2074289160, gnomAD 3-127599404-C-T, CADD 10.90
- S32F (p.Ser32Phe), gnomAD 3-127599406-C-T, REVEL 0.22, MetaLR 0.09
- R33P (p.Arg33Pro), 1000Genomes rs142494006, ExAC rs142494006, TOPMed rs142494006, gnomAD rs142494006, REVEL 0.16, MetaLR 0.08, Uncertain significance, not provided
- R33Q (p.Arg33Gln), rs142494006, ClinGen CA2595471, ClinVar RCV000912247, 1000Genomes rs142494006, REVEL 0.10, MetaLR 0.04, Benign/Likely benign, not provided
- R33W (p.Arg33Trp), ESP rs144051770, ExAC rs144051770, TOPMed rs144051770, gnomAD rs144051770, REVEL 0.15, MetaLR 0.10, Uncertain significance, not specified
- R33R (p.Arg33Arg), gnomAD 3-127599408-C-A, CADD 10.50
- R34C (p.Arg34Cys), ExAC rs758941392, TOPMed rs758941392, gnomAD rs758941392, REVEL 0.21, MetaLR 0.11
- R34H (p.Arg34His), ExAC rs749193916, TOPMed rs749193916, gnomAD rs749193916, REVEL 0.16, MetaLR 0.09, Uncertain significance
- R34P (p.Arg34Pro), rs749193916, ClinGen CA83303741, ClinVar RCV003733322, ClinVar RCV004636831, REVEL 0.22, MetaLR 0.09, Uncertain significance, not specified; not provided
- R34S (p.Arg34Ser), ExAC rs758941392, TOPMed rs758941392, gnomAD rs758941392, REVEL 0.15, MetaLR 0.07
- R34L (p.Arg34Leu), gnomAD 3-127599412-G-T, REVEL 0.21, MetaLR 0.07
- T35A (p.Thr35Ala), gnomAD 3-127599414-A-G, REVEL 0.02, MetaLR 0.04
- T35T (p.Thr35Thr), rs937897142, gnomAD 3-127599416-T-C, CADD 3.08
- D36N (p.Asp36Asn), NCI-TCGA Cosmic COSV5403, REVEL 0.13, MetaLR 0.08, Variant assessed as somatic; moderate impact.
- D36G (p.Asp36Gly), gnomAD 3-127599418-A-G, REVEL 0.29, MetaLR 0.07
- D36E (p.Asp36Glu), gnomAD 3-127599419-T-G, REVEL 0.12, MetaLR 0.05
- A37V (p.Ala37Val), TOPMed rs1055207216, gnomAD rs1055207216, REVEL 0.22, MetaLR 0.08
- A37T (p.Ala37Thr), gnomAD 3-127599420-G-A, REVEL 0.16, MetaLR 0.08
- A37S (p.Ala37Ser), gnomAD 3-127599420-G-T, REVEL 0.17, MetaLR 0.06
- A37A (p.Ala37Ala), rs747126098, gnomAD 3-127599422-C-T, CADD 13.30
- L38F (p.Leu38Phe), Ensembl rs1559859637, REVEL 0.03, MetaLR 0.06
- L38I (p.Leu38Ile), NCI-TCGA Cosmic COSV5403, Variant assessed as somatic; moderate impact.
- L38P (p.Leu38Pro), rs1559859642, gnomAD 3-127599423-CT-C, CADD 28.70
- L38L (p.Leu38Leu), gnomAD 3-127599425-C-T, CADD 9.60
- T39I (p.Thr39Ile), rs745488384, ClinGen CA2595475, ClinVar RCV001906978, ClinVar RCV004042719, REVEL 0.18, MetaLR 0.08, Uncertain significance, not provided; not specified
- T39P (p.Thr39Pro), Ensembl rs1576410104, REVEL 0.23, MetaLR 0.06
- T39T (p.Thr39Thr), rs777028345, gnomAD 3-127599428-C-T, CADD 13.10
- S40C (p.Ser40Cys), gnomAD rs1378187591, REVEL 0.26, MetaLR 0.15
- P42A (p.Pro42Ala), gnomAD rs1174580506, REVEL 0.22, MetaLR 0.12
- P42P (p.Pro42Pro), rs140680894, gnomAD 3-127599437-T-A, CADD 10.20
- G43D (p.Gly43Asp), gnomAD 3-127599439-G-A, REVEL 0.21, MetaLR 0.06
- G43G (p.Gly43Gly), rs775414015, gnomAD 3-127599440-C-T, CADD 11.00
- R44C (p.Arg44Cys), rs375851208, ClinGen CA2595480, ClinVar RCV000223937, UniProt VAR 077049, REVEL 0.24, MetaLR 0.12, no classifications from unflagged records, Autosomal dominant nonsyndromic hearing loss 70
- R44H (p.Arg44His), rs572334760, ClinGen CA2595481, ClinVar RCV004086700, 1000Genomes rs572334760, REVEL 0.28, MetaLR 0.14, Uncertain significance, not specified
- R44L (p.Arg44Leu), 1000Genomes rs572334760, ExAC rs572334760, TOPMed rs572334760, gnomAD rs572334760, REVEL 0.36, MetaLR 0.08, Uncertain significance, in DFNA70
- R44G (p.Arg44Gly), gnomAD 3-127599441-C-G, REVEL 0.25, MetaLR 0.07
- D45D (p.Asp45Asp), rs1271904626, gnomAD 3-127599446-C-T, CADD 12.90
- L46F (p.Leu46Phe), Ensembl rs2074290060, REVEL 0.15, MetaLR 0.06
- L46V (p.Leu46Val), gnomAD 3-127599447-C-G, REVEL 0.11, MetaLR 0.08
- P47P (p.Pro47Pro), gnomAD 3-127599452-A-G, CADD 9.63
- P48L (p.Pro48Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P48S (p.Pro48Ser), gnomAD rs2074290087, REVEL 0.22, MetaLR 0.29
- P48P (p.Pro48Pro), rs761404358, gnomAD 3-127599455-A-G, CADD 12.80
- F49Y (p.Phe49Tyr), gnomAD 3-127599457-T-A, REVEL 0.18, MetaLR 0.34
- E50D (p.Glu50Asp), rs1352111513, NCI-TCGA Cosmic COSV5403, TOPMed rs1352111513, gnomAD rs1352111513, REVEL 0.24, MetaLR 0.18, Variant assessed as somatic; moderate impact.
- D51H (p.Asp51His), NCI-TCGA Cosmic COSV5403, NCI-TCGA Cosmic COSV9941, Variant assessed as somatic; moderate impact.
- p.Asp51 Glu52del, rs780508768, gnomAD 3-127599457-TTGAG, CADD 22.20
- D51G (p.Asp51Gly), gnomAD 3-127599463-A-G, REVEL 0.41, MetaLR 0.34
- D51E (p.Asp51Glu), gnomAD 3-127599464-T-G, REVEL 0.15, MetaLR 0.21
- E52D (p.Glu52Asp), TOPMed rs2074290197, gnomAD rs2074290197, REVEL 0.09, MetaLR 0.15
- E52E (p.Glu52Glu), gnomAD 3-127599467-G-A, CADD 12.60
- S53C (p.Ser53Cys), TOPMed rs2074290230, gnomAD rs2074290230, REVEL 0.21, MetaLR 0.26
- S53P (p.Ser53Pro), gnomAD 3-127599468-T-C, REVEL 0.25, MetaLR 0.21
- S53S (p.Ser53Ser), rs572319263, gnomAD 3-127599470-C-T, CADD 5.02
- E54K (p.Glu54Lys), rs771946607, ClinGen CA83303800, ClinVar RCV003870632, TOPMed rs771946607, REVEL 0.20, MetaLR 0.20, Uncertain significance, not provided
- G55G (p.Gly55Gly), rs1482517451, gnomAD 3-127599476-G-T, CADD 9.62
- L56F (p.Leu56Phe), ExAC rs760296226, gnomAD rs760296226, REVEL 0.07, MetaLR 0.15
- L56L (p.Leu56Leu), rs765659379, gnomAD 3-127599479-C-A, CADD 10.10
- L57V (p.Leu57Val), ExAC rs753111466, gnomAD rs753111466
- T59I (p.Thr59Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E60D (p.Glu60Asp), ExAC rs758633607, TOPMed rs758633607, gnomAD rs758633607, REVEL 0.03, MetaLR 0.03
- E60V (p.Glu60Val), gnomAD 3-127599490-A-T, REVEL 0.03, MetaLR 0.04
- E60A (p.Glu60Ala), gnomAD 3-127599490-A-C, REVEL 0.04, MetaLR 0.03
- E60E (p.Glu60Glu), rs758633607, gnomAD 3-127599491-G-A, CADD 12.00
- G61E (p.Gly61Glu), ExAC rs778367347, TOPMed rs778367347, gnomAD rs778367347, REVEL 0.07, MetaLR 0.02
- G61V (p.Gly61Val), ExAC rs778367347, TOPMed rs778367347, gnomAD rs778367347, REVEL 0.02, MetaLR 0.03, Uncertain significance, not specified
- G61W (p.Gly61Trp), gnomAD 3-127599492-G-T, REVEL 0.10, MetaLR 0.08
- G61R (p.Gly61Arg), gnomAD 3-127599492-G-A, REVEL 0.06, MetaLR 0.05
- G61G (p.Gly61Gly), rs1430580053, gnomAD 3-127599494-G-T, CADD 9.62
- P62A (p.Pro62Ala), gnomAD rs1175630953
- P62T (p.Pro62Thr), gnomAD rs1175630953, REVEL 0.05, MetaLR 0.05
- P62L (p.Pro62Leu), gnomAD 3-127599496-C-T, REVEL 0.03, MetaLR 0.02
- L63L (p.Leu63Leu), rs1358348449, gnomAD 3-127599500-G-C, CADD 8.90
- E64K (p.Glu64Lys), gnomAD 3-127599501-G-A, REVEL 0.15, MetaLR 0.10
- E64E (p.Glu64Glu), rs1464400190, gnomAD 3-127599503-G-A, CADD 9.31
- E65K (p.Glu65Lys), Ensembl rs2107684298
- E65E (p.Glu65Glu), gnomAD 3-127599506-A-G, CADD 12.40
- E66D (p.Glu66Asp), ExAC rs757457211, gnomAD rs757457211, REVEL 0.09, MetaLR 0.04
- E66Q (p.Glu66Gln), ExAC rs751974456, gnomAD rs751974456, REVEL 0.14, MetaLR 0.24
- E66V (p.Glu66Val), TOPMed rs1343512840
- E66E (p.Glu66Glu), rs757457211, gnomAD 3-127599509-A-G, CADD 12.30
- E67G (p.Glu67Gly), 1000Genomes rs201221422, REVEL 0.15, MetaLR 0.07
- E67E (p.Glu67Glu), gnomAD 3-127599512-G-A, CADD 9.71
- D68E (p.Asp68Glu), rs3087452, ClinGen CA2595494, ClinVar RCV000838302, ClinVar RCV003975353, REVEL 0.10, MetaLR 0.01, Benign, not provided
- D68N (p.Asp68Asn), gnomAD rs775184023, REVEL 0.13, MetaLR 0.10
- D68G (p.Asp68Gly), gnomAD 3-127599514-A-G, REVEL 0.21, MetaLR 0.14
- G69R (p.Gly69Arg), gnomAD 3-127599516-G-A, REVEL 0.46, MetaLR 0.44
- E70K (p.Glu70Lys), gnomAD 3-127599519-G-A, REVEL 0.42, MetaLR 0.26
- E71A (p.Glu71Ala), TOPMed rs2074291027, REVEL 0.27, MetaLR 0.10
- E71D (p.Glu71Asp), rs796576308, ClinGen CA354381082, ClinVar RCV003817377, TOPMed rs796576308, REVEL 0.11, MetaLR 0.01, Uncertain significance, not provided
- E71* (p.Glu71Ter), gnomAD 3-127599522-G-T, CADD 39.00
- E71E (p.Glu71Glu), rs796576308, gnomAD 3-127599524-G-A, CADD 10.10
- I73T (p.Ile73Thr), gnomAD rs1331240380, REVEL 0.28, MetaLR 0.10
- I73V (p.Ile73Val), ExAC rs746153512, gnomAD rs746153512, REVEL 0.10, MetaLR 0.05
Public MCM2 analysis runs
- MCM2 analysis run — MCM2 (1,263 variants) — completed 2026-08-20